Overview
Sickle cell-thalassemia disease with crisis refers to acute complications arising from the interaction of sickle cell disease and thalassemia traits, often characterized by severe pain episodes, hemolysis, and potential organ dysfunction 1.Diagnosis
Fetal heart rate (FHR) abnormalities may indicate crisis severity in pregnant patients 1.
Monitoring for signs of acute chest syndrome, stroke, and severe anemia is crucial 1.
Laboratory tests include complete blood count (CBC), reticulocyte count, and hemoglobin electrophoresis 1.Management
First-line treatments: Pain management with opioids, hydration, and oxygen therapy as needed 1.
Adjunctive treatments: Hydroxyurea for chronic management to reduce crisis frequency 1.
Specific interventions: Propranolol administration to manage FHR abnormalities in pregnant patients with caution 1.Special Populations
Pregnancy: Immediate cesarean delivery may be contraindicated due to maternal health; symptomatic treatment like propranolol can be considered 1.
Comorbidities: Management should address both sickle cell crisis and underlying thalassemia complications concurrently 1.Key Recommendations
Symptomatic treatment with propranolol may stabilize FHR abnormalities in pregnant patients experiencing sickle cell crisis (Evidence: Weak) 1.
Avoid immediate cesarean delivery in pregnant patients with sickle cell crisis if maternal contraindications exist; consider alternative symptomatic treatments 1.
Utilize hydroxyurea for chronic management to reduce the frequency of sickle cell crises (Evidence: Moderate) 1.References
1 Katz M, Sokal MM, Lilling M. An undeliverable fetus with an ominous fetal heart pattern: an obstetric dilemma. Obstetrics and gynecology 1979. link